Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA384032
Max Phase: Preclinical
Molecular Formula: C13H15N3O2
Molecular Weight: 245.28
Molecule Type: Small molecule
Associated Items:
ID: ALA384032
Max Phase: Preclinical
Molecular Formula: C13H15N3O2
Molecular Weight: 245.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1NC(=O)NC2Cc3ccccc3CN2C1=O
Standard InChI: InChI=1S/C13H15N3O2/c1-8-12(17)16-7-10-5-3-2-4-9(10)6-11(16)15-13(18)14-8/h2-5,8,11H,6-7H2,1H3,(H2,14,15,18)/t8-,11?/m0/s1
Standard InChI Key: XWCIZSAKULYVKW-YMNIQAILSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 245.28 | Molecular Weight (Monoisotopic): 245.1164 | AlogP: 0.60 | #Rotatable Bonds: 0 |
Polar Surface Area: 61.44 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.14 | CX Basic pKa: | CX LogP: 0.46 | CX LogD: 0.46 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.70 | Np Likeness Score: 0.18 |
1. Muller P, Lena G, Boilard E, Bezzine S, Lambeau G, Guichard G, Rognan D.. (2006) In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors., 49 (23): [PMID:17154507] [10.1021/jm0606589] |
Source(1):